Citigroup analysts initiated coverage on GSK plc (NYSE:GSK) with a Buy rating on January 27, 2026.
GSK plc operates in the Healthcare sector. The stock currently trades at $50.10 with a market capitalization of $99.4B.
Citigroup analysts initiated coverage on GSK plc (NYSE:GSK) with a Buy rating on January 27, 2026. GSK plc operates in the Healthcare sector. The stock currently trades at $50.10…

Citigroup analysts initiated coverage on GSK plc (NYSE:GSK) with a Buy rating on January 27, 2026.
GSK plc operates in the Healthcare sector. The stock currently trades at $50.10 with a market capitalization of $99.4B.
Current market data
NYSE · GSK
Keep reading
dividends ·
institutional ·
earnings ·
earnings ·